Tag Archives: Federal

Payers balk at HHS proposal to end federal PBM rebates

The Trump administration’s announcement Thursday to end safe harbor protections for drug rebates through pharmacy benefit managers, Medicare Part D plans and Medicaid managed care organizations dinged payer stocks Friday and riled up the health insurance sector. The policy change was expected. Sky-high drug prices have been a frequent target of President Donald Trump and his… Read More »